US 11,084,843 B2Granted

Anticancer compounds

AssigneeGodavari Biorefineries Limited

InventorsVitthal Yadav, Maithili Athavale, Prashant Kharkar, Sangeeta Srivastava, Samir Somaiya, Smera Satish, Sandip Gavade

Life of this patent

Estimating the term…

Abstract

The present invention discloses compounds for inhibition of uncontrolled cell proliferation particularly in cancer stem cells. Particularly, the invention relates to compounds of Formula III to XIV for the treatment of cancer, such as breast and prostate cancer.

Claims6

Dependent claims

A compound of Formula V:

Dependencies are inferred from the claim text.

Facts

Application: 16/336,460Filed 19 Apr 2018
Priority: IN 20162103596720 Apr 2017
Published: US 2019/0284222 A119 Sep 2019
Granted: 10 Aug 2021
Term ends: Not estimatedThe source records don’t support an estimate.

Classification22 codes

C07H 15/26
Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals: acyclic or…
A61K 31/10
Sulfur, selenium, or tellurium compounds, e.g. thiols: sulfides; Sulfoxides; Sulfones
A61K 31/357
Having oxygen as the only ring hetero atom, e.g. fungichromin: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K 31/4025
Having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil: not condensed and…

Family

US 2019/0284222 A1Pre-grant publication · published 19 Sep 2019
US 11,084,843 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results